Prescription Drug Monitoring Programs: Evolution and Evidence

StartFragment

In his evaluation of important tools against the opioid epidemic, PISC researcher Zachary Meisel reviews the current status and characteristics of prescription drug monitoring programs, their uses, and evidence of their effectiveness.

Go to Story

Back to News